Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.19.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2018
Mar. 30, 2019
Dec. 30, 2017
Dec. 31, 2016
OPERATING ACTIVITIES        
Net income [1] $ 252,793 $ 1,259,792 $ 614,923 $ 1,074,106
Adjustments to reconcile net income to cash provided (used) by operating activities:        
Impairment of goodwill and intangible assets [1] 0 0 104,651 79,644
Depreciation and amortization [1] 71,532 301,005 290,503 281,577
Stock-based compensation [1] 25,440 105,157 81,641 67,762
Provision for doubtful accounts [1] 2,660 22,553 21,171 17,283
Pension expense (less than) in excess of contributions [1] 1,413 (1,850) 25,022 89,005
Deferred income taxes [1] 303 (62,901) (79,838) (71,625)
Loss on sale of businesses [1] 18,065 28,262 29,841 104,357
Other, net [1] (7,148) (31,612) (2,006) (15,232)
Changes in operating assets and liabilities:        
Accounts receivable [1] 38,686 (373,012) (107,083) 47,102
Inventories [1] (156,292) (135,099) 17,005 (37,210)
Accounts payable [1] (187,553) 111,678 21,494 (9,553)
Income taxes [1] (65,234) (19,974) 460,350 (129,574)
Accrued liabilities [1] (172,396) 484,858 31,928 28,904
Other assets and liabilities [1] (65,492) (24,634) (34,942) (45,978)
Cash provided (used) by operating activities [1] (243,223) 1,664,223 1,474,660 1,480,568
INVESTING ACTIVITIES        
Business acquisitions, net of cash received [1] 0 (320,405) (740,541) 0
Proceeds from sale of businesses, net of cash sold [1] 0 430,286 214,968 115,983
Capital expenditures [1] (54,374) (250,634) (169,553) (175,840)
Software purchases [1] (19,289) (56,207) (65,177) (44,226)
Other, net [1] 17,673 (23,672) (15,948) (8,331)
Cash used by investing activities [1] (55,990) (220,632) (776,251) (112,414)
FINANCING ACTIVITIES        
Net (decrease) increase in short-term borrowings [1] 795,908 (864,177) 686,453 (421,069)
Payments on long-term debt [1] (1,484) (6,264) (254,314) (13,276)
Payment of debt issuance costs [1] 0 (2,123) 0 (6,807)
Proceeds from long-term debt [1] 0 0 0 951,817
Purchases of treasury stock [1] (250,282) (150,676) (1,200,356) (1,000,468)
Cash dividends paid [1] (181,373) (767,061) (684,679) (635,994)
Proceeds from issuance of Common Stock, net of shares withheld for taxes [1] 44,017 199,296 89,893 48,918
Cash (used) provided by financing activities [1] 406,786 (1,591,005) (1,363,003) (1,076,879)
Effect of foreign currency rate changes on cash, cash equivalents and restricted cash [1] 12,220 14,811 2,965 (6,645)
Net change in cash, cash equivalents and restricted cash [1] 119,793 (132,603) (661,629) 284,630
Cash, cash equivalents and restricted cash — beginning of year [1] 569,397 689,190 1,231,026 946,396
Cash, cash equivalents and restricted cash — end of year [1] $ 689,190 $ 556,587 $ 569,397 $ 1,231,026
[1] The cash flows related to discontinued operations have not been segregated, and remain included in the major classes of assets and liabilities. Accordingly, the Consolidated Statements of Cash Flows include the results of continuing and discontinued operations.